
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Eucommia ulmoides is a traditional Chinese medicinal bark containing chlorogenic acid and geniposidic acid that supports cardiovascular health through ACE inhibition and nitric oxide enhancement. Clinical studies demonstrate its ability to reduce blood pressure by approximately 7.5/3.9 mmHg in hypertensive patients.

Origin & History

Eucommia ulmoides, also known as Duzhong or Tochu, is a deciduous tree native to China from temperate regions, cultivated for its bark, leaves, and seeds in traditional East Asian medicine. Extracts are typically prepared via aqueous or ethanolic methods from bark or leaves, yielding polyphenolic compounds classified as lignans, iridoids, and phenolics.
Research Narrative (Provisional)
Human clinical evidence is limited to small-scale studies, with a randomized placebo-controlled trial (PMID: 22214253) showing blood pressure reduction using standardized bark extract (8% pinoresinol di-beta-D-glucoside). An exploratory trial (PMID: 40575587) in 17 participants found significant blood pressure improvements, particularly in those with mild chronic kidney disease. Two multicenter RCTs for osteoarthritis are underway but results are pending (NCT03744611, PMID: 31852118).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Eucommia ulmoides bark (Du Zhong) is not consumed as a food source for macronutrients but contains a well-characterized array of bioactive compounds. Macronutrient content is negligible in typical therapeutic doses (3–15g dried bark). Key bioactive constituents include: (1) Lignans — pinoresinol diglucoside (0.1–0.5% dry weight), medioresinol, syringaresinol, identified as primary antihypertensive agents; (2) Iridoids — aucubin (~0.07–0.12% dry weight) and geniposide, contributing to anti-inflammatory and renal-protective effects; (3) Chlorogenic acid — a hydroxycinnamic acid derivative present at approximately 0.5–1.2% dry weight, contributing antioxidant and vasodilatory activity; (4) Gutta-percha (trans-polyisoprene) — a unique rubber-like polymer comprising 6–10% of bark dry weight, biologically inert but structurally distinctive; (5) Flavonoids — quercetin and rutin detected at trace levels (<0.05% dry weight); (6) Phenylpropanoids — including coniferin and syringin; (7) Minerals — bark contains modest calcium (~180–220 mg/100g dry weight), potassium (~300–400 mg/100g dry weight), magnesium (~50–80 mg/100g dry weight), and trace zinc and iron; (8) Dietary fiber — approximately 20–30% of dry bark weight as structural polysaccharides, though not consumed in fiber-relevant quantities in herbal doses. Bioavailability notes: Pinoresinol diglucoside requires gut microbiome conversion to aglycone forms for absorption; chlorogenic acid has moderate oral bioavailability (~30%); iridoid glycosides show variable absorption dependent on gut flora; standardized extracts (often to 1% pinoresinol diglucoside or 5% total iridoids) are used in clinical preparations to ensure consistent dosing.
Reported Mechanism (Provisional)
Eucommia's chlorogenic acid and geniposidic acid inhibit angiotensin-converting enzyme (ACE), reducing vasoconstriction and aldosterone release. The bark's lignans and iridoids enhance endothelial nitric oxide synthase activity, promoting vasodilation. Additional compounds like aucubin modulate calcium channels and support renal function through anti-inflammatory pathways.
Clinical Narrative (Provisional)
A randomized controlled trial demonstrated Eucommia extract reduced systolic blood pressure by 7.5 mmHg and diastolic by 3.9 mmHg in hypertensive patients over 8 weeks. A smaller preliminary study in 17 chronic kidney disease patients showed significant blood pressure improvements with daily supplementation. Current evidence is moderate quality with limited large-scale trials. Most studies used standardized bark extracts containing 3-5% chlorogenic acid at doses of 500-1000mg daily.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







